MARVIN MILLER Insider Trading $GTCB rEVO Biologics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARVIN MILLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARVIN MILLER. MARVIN MILLER is Director in rEVO Biologics, Inc. ($GTCB).
MARVIN MILLER in rEVO Biologics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MARVIN MILLER: Director
Holdings: 3,585 shares
Latest Transaction: Sep 28 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARVIN MILLER in rEVO Biologics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.76 | 683 | 1,201 | 3,585 | 2.9 K to 3.6 K (+23.54 %) |
| Jun 29 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 2.70 | 444 | 1,199 | 2,902 | 2.5 K to 2.9 K (+18.06 %) |
| May 29 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Option Exercise | A | 3.05 | 4,500 | 13,725 | 4,500 | |
| Mar 31 2009 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.33 | 3,636 | 1,200 | 24,584 | 20.9 K to 24.6 K (+17.36 %) |
| Dec 29 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.28 | 4,309 | 1,200 | 20,948 | 16.6 K to 20.9 K (+25.90 %) |
| Sep 29 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.37 | 3,243 | 1,200 | 16,639 | 13.4 K to 16.6 K (+24.21 %) |
| Jun 30 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.40 | 2,985 | 1,200 | 13,396 | 10.4 K to 13.4 K (+28.67 %) |
| Apr 01 2008 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.55 | 2,182 | 1,200 | 10,411 | 8.2 K to 10.4 K (+26.52 %) |
| Dec 28 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 0.87 | 1,379 | 1,200 | 8,229 | 6.9 K to 8.2 K (+20.13 %) |
| Oct 02 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.02 | 1,176 | 1,200 | 6,850 | 5.7 K to 6.9 K (+20.73 %) |
| Jul 02 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.15 | 1,043 | 1,199 | 5,674 | 4.6 K to 5.7 K (+22.52 %) |
| May 25 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Option Exercise | A | 1.18 | 15,000 | 17,700 | 15,000 | |
| Apr 03 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.02 | 781 | 800 | 4,631 | 3.9 K to 4.6 K (+20.29 %) |
| Jan 03 2007 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.11 | 721 | 800 | 3,850 | 3.1 K to 3.9 K (+23.04 %) |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Option Exercise | A | 0.89 | 22,500 | 20,025 | 22,500 | |
| Nov 16 2006 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.24 | 1,129 | 1,400 | 3,129 | 2 K to 3.1 K (+56.45 %) |
| May 12 2004 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.85 | 400 | 740 | 2,000 | 1.6 K to 2 K (+25.00 %) |
| May 12 2004 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.84 | 100 | 184 | 1,600 | 1.5 K to 1.6 K (+6.67 %) |
| May 12 2004 | GTCB | rEVO Biologics, In ... | MILLER MARVIN | Director | Grant | A | 1.83 | 1,500 | 2,745 | 1,500 | 0 to 1.5 K |
Page: 1